Annual CFI
$52.54 M
+$273.52 M+123.77%
December 31, 2023
Summary
- As of February 7, 2025, DSGN annual cash flow from investing activities is $52.54 million, with the most recent change of +$273.52 million (+123.77%) on December 31, 2023.
- During the last 3 years, DSGN annual CFI has risen by +$86.10 million (+256.54%).
- DSGN annual CFI is now at all-time high.
Performance
DSGN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$5.83 M
-$33.16 M-121.31%
September 30, 2024
Summary
- As of February 7, 2025, DSGN quarterly cash flow from investing activities is -$5.83 million, with the most recent change of -$33.16 million (-121.31%) on September 30, 2024.
- Over the past year, DSGN quarterly CFI has dropped by -$33.16 million (-121.31%).
- DSGN quarterly CFI is now -121.31% below its all-time high of $27.33 million, reached on June 30, 2024.
Performance
DSGN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$47.68 M
-$21.09 M-30.67%
September 30, 2024
Summary
- As of February 7, 2025, DSGN TTM cash flow from investing activities is $47.68 million, with the most recent change of -$21.09 million (-30.67%) on September 30, 2024.
- Over the past year, DSGN TTM CFI has dropped by -$21.09 million (-30.67%).
- DSGN TTM CFI is now -30.67% below its all-time high of $68.77 million, reached on June 30, 2024.
Performance
DSGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
DSGN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +123.8% | -121.3% | -30.7% |
| 3 y3 years | +256.5% | -15.6% | +3104.3% |
| 5 y5 years | +100.0% | +85.2% | +221.5% |
DSGN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.8% | -121.3% | +96.3% | -30.7% | +117.7% |
| 5 y | 5-year | at high | +123.8% | -121.3% | +96.3% | -30.7% | +117.7% |
| alltime | all time | at high | +123.8% | -121.3% | +96.3% | -30.7% | +117.7% |
Design Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.83 M(-121.3%) | $47.68 M(-30.7%) |
| Jun 2024 | - | $27.33 M(+32.6%) | $68.77 M(+28.7%) |
| Mar 2024 | - | $20.62 M(+271.1%) | $53.42 M(+1.7%) |
| Dec 2023 | $52.54 M(-123.8%) | $5.55 M(-63.6%) | $52.54 M(+14.4%) |
| Sep 2023 | - | $15.27 M(+27.4%) | $45.92 M(-240.3%) |
| Jun 2023 | - | $11.98 M(-39.3%) | -$32.73 M(-83.8%) |
| Mar 2023 | - | $19.73 M(-1968.7%) | -$201.67 M(-8.7%) |
| Dec 2022 | -$220.99 M | -$1.06 M(-98.3%) | -$220.99 M(-18.1%) |
| Sep 2022 | - | -$63.39 M(-59.6%) | -$269.99 M(+27.6%) |
| Jun 2022 | - | -$156.96 M(<-9900.0%) | -$211.64 M(+177.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $414.00 K(-100.8%) | -$76.26 M(+42.2%) |
| Dec 2021 | -$53.64 M(+59.8%) | -$50.06 M(+892.8%) | -$53.64 M(+3280.2%) |
| Sep 2021 | - | -$5.04 M(-76.6%) | -$1.59 M(-123.9%) |
| Jun 2021 | - | -$21.57 M(-193.7%) | $6.64 M(-76.9%) |
| Mar 2021 | - | $23.03 M(+1052.6%) | $28.71 M(-185.6%) |
| Dec 2020 | -$33.56 M(<-9900.0%) | $2.00 M(-37.3%) | -$33.56 M(-5.6%) |
| Sep 2020 | - | $3.19 M(+536.1%) | -$35.56 M(-8.2%) |
| Jun 2020 | - | $501.00 K(-101.3%) | -$38.75 M(-1.3%) |
| Mar 2020 | - | -$39.25 M | -$39.25 M |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Design Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Design Therapeutics?
- What is Design Therapeutics annual CFI year-on-year change?
- What is Design Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Design Therapeutics?
- What is Design Therapeutics quarterly CFI year-on-year change?
- What is Design Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Design Therapeutics?
- What is Design Therapeutics TTM CFI year-on-year change?
What is Design Therapeutics annual cash flow from investing activities?
The current annual CFI of DSGN is $52.54 M
What is the all time high annual CFI for Design Therapeutics?
Design Therapeutics all-time high annual cash flow from investing activities is $52.54 M
What is Design Therapeutics annual CFI year-on-year change?
Over the past year, DSGN annual cash flow from investing activities has changed by +$273.52 M (+123.77%)
What is Design Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of DSGN is -$5.83 M
What is the all time high quarterly CFI for Design Therapeutics?
Design Therapeutics all-time high quarterly cash flow from investing activities is $27.33 M
What is Design Therapeutics quarterly CFI year-on-year change?
Over the past year, DSGN quarterly cash flow from investing activities has changed by -$33.16 M (-121.31%)
What is Design Therapeutics TTM cash flow from investing activities?
The current TTM CFI of DSGN is $47.68 M
What is the all time high TTM CFI for Design Therapeutics?
Design Therapeutics all-time high TTM cash flow from investing activities is $68.77 M
What is Design Therapeutics TTM CFI year-on-year change?
Over the past year, DSGN TTM cash flow from investing activities has changed by -$21.09 M (-30.67%)